STRS Ohio’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-285,500
| Closed | -$204K | – | 2037 |
|
|
2022
Q1 | $204K | Hold |
285,500
| – | – | ﹤0.01% | 1705 |
|
|
2021
Q4 | $645K | Hold |
285,500
| – | – | ﹤0.01% | 1392 |
|
|
2021
Q3 | $822K | Buy |
285,500
+55,700
| +24% | +$160K | ﹤0.01% | 1235 |
|
|
2021
Q2 | $870K | Buy |
229,800
+11,400
| +5% | +$43.2K | ﹤0.01% | 1253 |
|
|
2021
Q1 | $739K | Hold |
218,400
| – | – | ﹤0.01% | 1385 |
|
|
2020
Q4 | $611K | Hold |
218,400
| – | – | ﹤0.01% | 1369 |
|
|
2020
Q3 | $548K | Buy |
218,400
+148,500
| +212% | +$373K | ﹤0.01% | 1277 |
|
|
2020
Q2 | $949K | Buy |
69,900
+62,900
| +899% | +$854K | ﹤0.01% | 912 |
|
|
2020
Q1 | $53K | Buy |
+7,000
| New | +$53K | ﹤0.01% | 1775 |
|
|
2019
Q4 | – | Sell |
-47,800
| Closed | -$187K | – | 2054 |
|
|
2019
Q3 | $187K | Hold |
47,800
| – | – | ﹤0.01% | 1663 |
|
|
2019
Q2 | $231K | Buy |
47,800
+2,700
| +6% | +$13K | ﹤0.01% | 1666 |
|
|
2019
Q1 | $369K | Buy |
45,100
+2,300
| +5% | +$18.8K | ﹤0.01% | 1456 |
|
|
2018
Q4 | $236K | Buy |
42,800
+17,700
| +71% | +$97.6K | ﹤0.01% | 1599 |
|
|
2018
Q3 | $221K | Sell |
25,100
-1,500
| -6% | -$13.2K | ﹤0.01% | 1695 |
|
|
2018
Q2 | $265K | Sell |
26,600
-25,100
| -49% | -$250K | ﹤0.01% | 1663 |
|
|
2018
Q1 | $492K | Hold |
51,700
| – | – | ﹤0.01% | 1324 |
|
|
2017
Q4 | $768K | Buy |
51,700
+5,700
| +12% | +$84.7K | ﹤0.01% | 1034 |
|
|
2017
Q3 | $904K | Hold |
46,000
| – | – | ﹤0.01% | 923 |
|
|
2017
Q2 | $661K | Buy |
+46,000
| New | +$661K | ﹤0.01% | 1170 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 1861 |
|
|
2015
Q1 | – | Sell |
-2,700
| Closed | -$31K | – | 1804 |
|
|
2014
Q4 | $31K | Hold |
2,700
| – | – | ﹤0.01% | 1658 |
|
|
2014
Q3 | $60K | Buy |
+2,700
| New | +$60K | ﹤0.01% | 1625 |
|